medic
evalu
sensorineur
hear
loss
snhl
involv
combin
nongenet
laboratori
radiograph
test
former
provid
littl
diagnost
prognost
inform
radiograph
evalu
help
diagnos
tempor
bone
anomali
expens
requir
sedat
gener
anaesthesia
children
addit
test
timeconsum
stress
child
famili
recent
genet
test
gene
ad
diagnost
evalu
mutat
gene
account
children
nonsyndrom
snhl
recent
data
demonstr
util
analysi
determin
prognosi
best
intervent
recurr
risk
futur
children
famili
member
genet
test
also
predict
absenc
onset
syndrom
clinic
problem
may
present
birth
earli
childhood
eg
adolescentonset
blind
usher
syndrom
genet
etiolog
determin
larg
cohort
patient
provid
better
understand
genotypephenotyp
correl
exist
gene
examin
could
direct
specif
therapeut
intervent
beyond
uncertain
genet
mutat
next
preval
patient
hear
loss
gene
thought
play
signific
role
childhood
hear
loss
includ
usher
type
gene
eg
otof
though
studi
look
mani
gene
appreci
rel
contribut
identif
gene
caus
snhl
make
imper
develop
highthroughput
resequenc
assay
technolog
would
allow
comprehens
therefor
higher
yield
diagnost
evalu
etiolog
hear
loss
patient
current
technolog
allow
widespread
screen
common
gene
relat
snhl
ie
recent
advanc
molecular
microarray
technolog
made
feasibl
rapidli
screen
dna
sampl
thousand
possibl
genet
mutat
advantag
microarraybas
screen
includ
accuraci
simplic
effici
costeffect
employ
larg
scale
howev
call
rate
among
differ
microarray
design
may
vari
consider
comput
method
reduct
fals
posit
due
systemat
effect
previous
propos
inadequ
call
coverag
also
consider
limit
resequenc
arraybas
approach
effici
sequencespecif
hybrid
depend
properti
probe
target
sequenc
high
gccontent
presenc
nearbi
snp
crosshybrid
sequenc
known
affect
basecal
thu
limit
capac
resequenc
microarray
shown
crich
probe
perform
better
complementari
grich
probe
addit
report
nearli
nocal
resolv
visual
inspect
intens
one
strand
provid
clear
signatur
posit
howev
exist
comput
approach
leverag
sequencespecif
characterist
attempt
resolv
gseq
nocal
distinct
signatur
one
strand
still
rule
nocal
due
improp
hybrid
complementari
strand
gseq
known
produc
fals
neg
thu
provid
highli
sensit
test
howev
followup
dideoxi
sequenc
resolut
nocal
lead
addit
variabl
cost
factor
need
care
consid
clinic
applic
technolog
effect
propos
novel
algorithm
resolut
nocal
gseq
note
algorithm
design
altern
gseq
instead
provid
option
step
salvag
unresolv
base
gseq
initi
confirmatori
dideoxi
sequenc
work
focus
evalu
effect
resequenc
array
tool
variant
detect
discuss
impact
basecal
adopt
addit
comput
algorithm
laboratori
protocol
studi
present
result
hear
loss
array
develop
two
differ
research
facil
highlight
approach
adopt
enhanc
applic
array
clinic
set
harvard
array
contain
gene
see
method
perform
characterist
determin
data
analyz
set
array
run
protocol
optim
tabl
averag
base
call
rate
across
array
base
use
affymetrix
gda
confirm
everi
variant
call
dideoxi
sequenc
determin
fals
posit
rate
averag
variant
call
per
array
true
variant
rest
fals
posit
dideoxi
sequenc
base
across
array
perform
data
compar
array
call
factor
fals
neg
fals
posit
obtain
averag
base
call
accuraci
across
array
cincinnati
array
also
contain
gene
common
harvard
array
see
method
ran
array
pilot
batch
character
array
perform
base
call
rate
array
base
rang
averag
call
rate
use
gseq
figur
dideoxi
sequenc
perform
base
comparison
data
array
call
gave
call
accuraci
nearli
fals
posit
per
array
compar
data
cincinnati
harvard
array
number
nocal
fals
posit
former
found
higher
earli
data
harvard
array
shown
call
rate
worsen
fragment
incomplet
base
affect
within
long
rang
pcr
fragment
addit
reproduc
quantiti
product
long
rang
pcr
less
base
upon
two
factor
target
amplif
process
cincinnati
array
modifi
instead
use
combin
long
short
rang
pcr
fragment
rang
base
length
employ
pilot
batch
long
rang
pcr
convert
short
rang
result
fragment
rang
base
length
impact
use
shorter
pcr
product
evalu
compar
array
data
across
two
protocol
figur
total
array
base
run
optim
short
rang
pcr
protocol
averag
call
rate
rang
obtain
gseq
tabl
dideoxi
sequenc
perform
base
comparison
data
array
call
gave
array
call
accuraci
averag
number
fals
posit
drop
per
array
modifi
protocol
shorter
pcr
product
adopt
subsequ
array
dideoxi
sequenc
identifi
four
case
least
one
insert
delet
homozyg
previous
report
therefor
probe
tile
array
detect
addit
file
analyz
array
data
look
nocal
variant
call
vicin
indel
site
observ
pattern
allel
note
local
high
gccontent
surround
stretch
gs
probe
gc
stretch
cs
probe
gc
would
expect
make
detect
extrem
difficult
hand
continu
stretch
nocal
variant
call
span
delet
base
gene
led
detect
mutat
also
analyz
raw
featur
intens
within
fragment
see
indel
caus
degrad
intens
surround
variant
site
observ
lower
peak
intens
surround
mutat
find
evid
either
singl
base
delet
data
shown
gdasgseq
current
design
identifi
indel
low
detect
rate
expect
observ
agreement
previous
report
find
observ
increas
probe
g
ccontent
differenti
impact
perform
use
complementari
featur
quartet
determin
intens
associ
c
gcontent
probe
intens
characterist
vari
differ
respect
increas
c
gcontent
averag
peak
intens
affect
sever
high
gcontent
equal
high
ccontent
figur
order
assess
data
demonstr
previous
report
debilit
effect
stretch
gs
gstack
probe
perform
compar
hybrid
intens
among
probe
gcontent
group
base
presenc
absenc
gstretch
gs
continu
stretch
gcontent
probe
gstretch
produc
lower
peak
intens
probe
cstretch
without
stretch
gs
cs
figur
sprofil
use
nocal
gdasgseq
examin
base
call
wildtyp
base
singlestrand
evid
left
nocal
depend
upon
featur
intens
profil
base
call
subsequ
compar
gseq
dideoxi
sequenc
call
tabl
figur
provid
detail
comparison
call
rate
number
fals
posit
fals
neg
analyz
gseq
call
sprofil
cincinnati
array
run
short
long
rang
pcr
fragment
averag
call
rate
increas
call
accuraci
averag
number
nocal
drop
per
array
number
fals
posit
drop
base
per
array
improv
obtain
cost
incorrectli
assign
addit
true
variant
per
array
wildtyp
optmiz
cincinnati
array
averag
call
rate
increas
rang
call
accuraci
number
nocal
drop
tabl
number
fals
posit
drop
per
array
applic
filter
screen
variant
call
base
low
qualiti
score
number
nocal
variant
call
vicin
improv
achiev
cost
addit
fals
neg
per
array
also
calcul
number
exon
per
array
would
need
interrog
dideoxi
sequenc
order
resolv
nocal
confirm
posit
call
process
gseq
call
sprofil
averag
number
exon
sequenc
order
clarifi
nocal
confirm
variant
drop
rang
rang
per
array
use
sprofil
harvard
array
averag
call
rate
increas
number
nocal
drop
per
array
tabl
fals
posit
call
could
reduc
per
array
filter
fals
posit
call
addit
variant
fals
call
wildtyp
use
algorithm
nocal
follow
dideoxi
sequenc
implement
sprofil
result
substanti
fewer
exon
averag
need
followup
detail
list
variant
associ
frequenc
patient
cohort
control
popul
includ
addit
file
total
true
variant
detect
across
harvard
array
call
wildtyp
gda
tabl
interestingli
miss
variant
repres
singl
common
snp
c
seen
differ
array
appear
singl
substitut
may
problemat
basi
poor
sensit
variant
appear
overal
high
gccontent
local
gc
stretch
one
adjac
base
g
variant
repres
rare
variant
mani
potenti
clinic
signific
none
miss
array
although
assign
nocal
true
variant
identifi
across
optim
cincinnati
array
synonym
variant
call
wildtyp
gseq
tabl
variant
found
lie
within
gc
stretch
probe
gccontent
respect
variant
associ
high
gccontent
gc
stretch
exclud
synonym
andor
common
variant
patient
examin
cincinnati
array
patient
examin
harvard
array
least
one
variant
potenti
like
clinic
signific
exclud
two
case
known
biallel
mutat
see
addit
file
full
list
variant
found
per
patient
basi
assess
likelihood
variant
may
diseasecaus
effort
current
underway
examin
variant
control
studi
use
silico
algorithm
predict
protein
impact
studi
complet
variant
potenti
clinic
signific
confirm
clia
environ
result
return
patient
irb
approv
protocol
serial
molecular
techniqu
eg
direct
sequenc
singlestrand
conform
analysi
denatur
gradient
gel
electrophoresi
denatur
highperform
liquid
chromatographi
employ
detect
mutat
associ
disord
show
high
genet
allel
heterogen
labori
requir
high
turnaround
time
show
littl
differ
direct
cost
per
base
high
convent
serial
method
especi
ineffect
screen
larg
gene
without
definit
hot
spot
diseaseassoci
mutat
although
new
advanc
next
gener
sequenc
soon
replac
larg
scale
sequenc
platform
technolog
still
costli
medium
size
applic
target
diseas
sequenc
highdens
oligonucleotid
microarray
provid
effici
econom
competit
method
genet
screen
heterogen
disord
allow
parallel
resequenc
multipl
gene
singl
experi
sinc
first
studi
report
detect
known
genom
variant
use
oligonucleotid
array
sever
other
publish
describ
principl
resequenc
array
technolog
applic
genotyp
prokaryot
eukaryot
develop
two
resequenc
microarray
contain
uniqu
gene
implic
nonsyndrom
snhl
array
base
call
compar
dideoxi
sequenc
determin
accuraci
optim
protocol
data
analysi
method
similar
highqual
perform
measur
could
achiev
microarray
develop
two
independ
research
facil
contain
differ
set
gene
critic
perform
characterist
attempt
understand
optim
call
rate
sensit
specif
affymetrix
gseq
upgrad
version
gda
basecal
softwar
offer
addit
featur
describ
gseq
technic
datasheet
http
wwwaffymetrixcomsupporttechnicaldatasheetsgseqdatasheetpdf
howev
employ
basecal
algorithm
built
upon
adapt
background
genotypingcal
scheme
abacu
develop
cutler
colleagu
gda
gseq
produc
fals
neg
algorithm
conserv
make
wildtyp
call
fals
posit
nocal
repres
lack
test
sensit
follow
dideoxi
sequenc
howev
compromis
costeffect
technolog
larg
amount
sequenc
requir
hand
cost
reduct
roughli
reduct
compar
tradit
capillari
sequenc
thorough
followup
employ
resolv
variant
call
rare
nocal
exact
reduct
depend
degre
multiplex
employ
upfront
pcr
step
amount
followup
sequenc
need
latter
factor
uniqu
test
depend
sequenc
includ
pcr
robust
amount
dna
variat
region
test
degre
bioinformat
test
optim
achiev
previous
suggest
larg
pcr
amplicon
hybrid
effici
immobil
probe
possibl
due
steric
constraint
approach
target
dna
find
taken
consider
design
nucleic
acid
amplif
strategi
optim
target
amplif
process
includ
short
rang
pcr
improv
overal
array
perform
cincinnati
array
thu
provid
evid
relationship
pcr
amplicon
length
hybrid
effici
note
data
gener
harvard
array
base
upon
combin
short
rang
long
rang
pcr
howev
harvard
group
also
discontinu
use
long
rang
pcr
subsequ
develop
arraybas
sequenc
test
effort
need
continu
optim
fragment
long
rang
pcr
fragment
addit
limit
caus
diminish
dna
quantiti
variabl
amplif
effici
long
rang
pcr
outweigh
benefit
nuclear
gene
dispers
exon
one
hand
exon
combin
long
rang
pcr
reaction
limit
effici
gain
approach
contrast
amplif
long
stretch
contigu
interrog
dna
present
mitochondri
genom
enabl
highest
effici
save
longrang
pcr
approach
averag
call
rate
harvard
array
optim
cincinnati
array
respect
achiev
use
gdasgseq
previou
resequenc
arraybas
studi
report
call
rate
rang
gdasgseq
call
rate
within
high
end
report
rang
larg
percentag
tile
exon
requir
sequenc
followup
ambigu
call
repres
limit
clinic
applic
technolog
current
methodolog
well
known
gccontent
probe
impact
hybrid
http
wwwaffymetrixcomsupporttechnicaltechnotescustomseqarraybasetechnotepdf
crich
probe
perform
better
grich
probe
ident
site
complementari
strand
quartet
compar
fluoresc
intens
declin
grich
probe
addit
base
within
gstretch
probe
produc
lower
peak
intens
especi
stretch
continu
gs
previous
suggest
probe
multipl
gs
row
gstack
tend
higher
crosshybrid
signal
possibl
caus
format
gquartet
due
multiplex
bind
taken
togeth
find
impli
site
interrog
grich
probe
may
show
stronger
signal
complementari
strand
employ
crich
probe
appli
addit
comput
algorithm
sprofil
reduc
gdasgseq
nocal
util
distinct
signal
either
strand
nocal
could
resolv
harvard
cincinnati
array
respect
maintain
overal
accuraci
mutat
gcrich
region
previous
report
miss
also
observ
variant
could
correctli
identifi
associ
lower
gccontent
probe
compar
miss
addit
file
adjust
probe
length
posit
known
variabl
base
either
end
probe
suggest
improv
variant
detect
gcrich
region
small
indel
constitut
nearli
diseasecaus
mutat
human
gene
mutat
databas
novemb
shown
caus
sever
phenotyp
variabl
inabl
resequenc
array
high
sensit
detect
novel
indel
especi
involv
base
pair
present
signific
limit
region
show
aberr
hybrid
pattern
select
confirmatori
dideoxi
sequenc
potenti
detect
variat
includ
indel
miss
resequenc
array
howev
evid
data
small
indel
present
challeng
sometim
lead
easili
discern
variabl
hybrid
pattern
interrog
three
differ
delet
array
could
detect
largest
delet
seri
nocal
variant
call
region
algorithm
technic
improv
could
entail
develop
scheme
detect
indel
virtu
identifi
region
drop
signal
intens
although
observ
singl
intens
drop
one
indel
includ
valid
modif
technic
protocol
limit
secondari
amplif
signal
origin
employ
increas
detect
low
level
transcript
express
array
may
necessari
resequenc
array
interrog
germlin
nuclear
dna
variat
present
least
signal
compar
wildtyp
protocol
modif
could
lead
better
discrimin
signal
intens
drop
across
region
indel
interim
employ
clinic
oligo
hybrid
base
sequenc
technolog
diseas
mutat
substitut
eg
noonan
syndrom
cardiomyopathi
diseas
recess
eg
hear
loss
detect
aim
find
least
one
pathogen
variant
follow
capillari
sequenc
relev
gene
detect
second
mutat
may
miss
although
minor
loss
analyt
sensit
incur
use
hybrid
base
sequenc
balanc
increas
effici
diminish
cost
technolog
compar
tradit
approach
resequenc
arraybas
mutat
detect
report
produc
throughput
nearli
patient
per
technician
per
month
thu
use
method
initi
genet
screen
supplement
convent
dideoxi
sequenc
sampl
array
identifi
caus
mutat
hand
technolog
allow
us
cut
cost
test
roughli
half
compar
dideoxi
capillari
sequenc
approach
also
employ
clinic
laboratori
implement
technolog
four
differ
clinic
test
includ
hcm
cardiochip
dcm
cardiochip
noonan
spectrum
chip
otochip
describ
http
pcpgmpartnersorglmm
conclus
describ
hear
loss
gene
chip
repres
first
resequenc
array
molecular
test
nonsyndrom
pediatr
snhl
use
experiment
protocol
addit
comput
algorithm
describ
technolog
provid
rapid
costeffect
reason
accur
method
identifi
known
novel
sequenc
variant
target
dna
region
howev
followup
sequenc
requir
resolv
nocal
fals
posit
limit
costeffect
technolog
patient
sampl
clinic
inform
collect
irbapprov
protocol
case
recruit
clinic
center
patient
ohio
j
greinwald
massachusett
h
rehm
kenna
belgium
g
van
camp
israel
k
avraham
iowa
r
smith
nebraska
p
kelley
remain
repres
anonym
sampl
obtain
clinic
test
laboratori
molecular
medicin
partner
center
person
genet
medicin
patient
previous
test
neg
biallel
mutat
except
patient
heterozyg
mutat
gene
patient
bilater
snhl
either
recess
case
eg
affect
sibl
singleton
dna
clinic
inform
collect
patient
deidentifi
clinic
inform
case
anonym
includ
demograph
inform
audiometr
profil
famili
histori
neurootolog
histori
physic
examin
determin
gene
place
finit
resequenc
platform
initi
capabl
accommod
less
bp
undertook
comprehens
literatur
search
estim
like
frequenc
mutat
gene
known
caus
childhood
snhl
base
preval
mutat
publish
popul
famili
studi
inherit
pattern
mutat
ie
prefer
recess
childhood
hear
loss
impact
gene
patient
outcom
eg
blind
develop
due
usher
syndrom
initi
set
gene
select
inclus
one
hear
loss
array
eg
otof
due
space
limit
conserv
portion
tile
gene
extrem
limit
data
rel
contribut
therefor
sever
gene
select
base
upon
minor
characterist
eg
contribut
domin
recess
hear
loss
eg
interest
discov
larger
undocu
role
hear
loss
eg
andor
small
gene
size
fill
remain
capac
array
eg
tmie
note
current
studi
suggest
mutat
may
caus
hear
loss
detail
sequenc
includ
method
addit
file
two
array
design
one
univers
cincinnatichildren
hospit
medic
center
cincinnati
oh
one
harvard
medic
school
boston
gene
array
repres
total
uniqu
gene
assess
cincinnati
array
contain
exon
code
sequenc
otof
gene
harvard
array
contain
otof
tmie
gene
gene
code
sequenc
splice
junction
assess
cincinnati
array
bp
flank
splice
site
tile
exon
harvard
array
bp
flank
splice
site
tile
exon
addit
file
contain
overview
gene
tile
array
array
contain
probe
interrog
roughli
base
dna
probe
repres
base
assess
forward
strand
base
assess
revers
strand
addit
probe
design
detect
previous
report
insert
delet
also
tile
harvard
array
addit
file
initi
array
run
accord
manufactur
protocol
affymetrix
santa
clara
ca
briefli
long
rang
pcr
condit
la
takara
polymeras
takara
japan
takara
la
taq
uul
la
pcr
buffer
ii
um
dntp
um
primer
ngul
genom
dna
ul
reaction
volum
short
rang
pcr
condit
describ
dideoxi
sequenc
cycl
condit
reaction
min
sec
min
min
modif
use
standard
approach
pcr
optim
made
difficult
reaction
pcr
assay
either
quantifi
use
picogreen
molecular
probe
eugen
absorb
spectrometri
pool
equimolar
amount
pcr
product
purifi
fragment
label
hybrid
array
final
array
wash
scan
data
analyz
use
genechip
dna
analysi
softwar
gda
affymetrix
genechip
sequenc
analysi
softwar
gseq
affymetrix
initi
experi
cincinnati
protocol
modifi
includ
short
rang
pcr
order
increas
pcr
fragment
consist
facilit
use
autom
addit
pcr
product
clean
robot
use
magnet
bead
less
fragment
reagent
use
suggest
u
vs
recommend
u
fragment
product
analyz
use
agil
bioanalyz
santa
clara
ca
complet
dideoxi
sequenc
exon
perform
harvard
patient
array
cincinnati
array
enabl
assess
fals
neg
rate
partial
sequenc
perform
remain
patient
order
confirm
clarifi
base
assign
variant
call
affymetrix
gda
gseq
softwar
pcr
condit
amplitaq
gold
appli
biosystem
foster
citi
ca
uul
abi
pcr
buffer
mm
um
dntp
um
primer
ngul
genom
dna
ul
reaction
volum
modif
use
standard
approach
pcr
optim
made
difficult
reaction
cycl
condit
min
sec
sec
sec
min
sequenc
reaction
perform
use
primer
shortrang
pcr
intern
primer
longrang
follow
condit
big
dye
appli
biosystem
big
dye
buffer
dmso
primer
ul
templat
ng
total
volum
cycl
sequenc
condit
min
sec
sec
min
reaction
clean
use
cleanseq
magnet
bead
agencourt
bioscienc
corp
beverli
run
abi
dna
analyz
appli
biosystem
chromatogram
analyz
use
autom
phred
analysi
program
check
qualiti
follow
analysi
use
sequench
genecod
ann
arbor
mi
andor
mutat
surveyor
softgenet
state
colleg
pa
softwar
affymetrix
gda
optim
set
addit
file
use
assign
base
call
harvard
array
gseq
use
cincinnati
array
algorithm
set
determin
evalu
differ
qualiti
score
threshold
compar
array
call
dideoxi
sequenc
result
character
coverag
accuraci
set
chosen
optim
highest
call
rate
without
increas
fals
neg
rate
also
develop
novel
algorithm
sprofil
strandspecif
probe
cell
intens
comparison
filter
gdasgseq
base
call
algorithm
develop
reexamin
gdasgseq
output
reduc
nocal
case
fals
posit
sprofil
attempt
resolv
nocal
base
intens
signatur
singl
strand
base
call
due
poor
hybrid
one
strand
algorithm
use
wildtyp
base
within
array
determin
threshold
peak
next
highest
intens
ratio
either
strand
use
base
call
posit
interest
across
array
determin
proport
wildtyp
call
made
posit
gseq
latter
use
scale
threshold
ratio
thu
effect
make
algorithm
conserv
attempt
assign
wildtyp
call
posit
call
variant
larg
number
sampl
viceversa
also
adopt
two
addit
bioinformat
filter
develop
francisella
tularensi
wholegenom
resequenc
platform
filter
design
reduct
fals
posit
screen
variant
call
region
rich
variant
call
nocal
low
qualiti
score
correspond
base
call
except
wildtyp
call
within
nocal
stretch
sprofil
attempt
reexamin
base
call
conform
refer
sequenc
gda
gseq
conserv
make
wildtyp
call
thu
achiev
low
fals
neg
rate
output
call
compar
sequenc
result
gdasgseq
call
valid
sprofil
implement
matlab
detail
descript
sprofil
accompani
matlab
code
provid
addit
file
snhl
sensorineur
hear
loss
snp
singl
nucleotid
polymorph
pcr
polymeras
chain
reaction
gda
genechip
dna
analysi
softwar
gseq
genechip
sequenc
analysi
softwar
indel
insertiondelet
sprofil
strandspecif
probe
cell
intens
comparison
filter
gdasgseq
call
je
ah
perform
dna
prepar
chip
hybrid
cincinnati
array
ah
analyz
patientspecif
resequenc
data
assist
obtain
dideoxi
sequenc
read
sc
perform
laboratori
work
raw
data
analysi
harvard
array
mak
submit
patient
analysi
harvard
array
hlr
oversaw
work
harvard
array
pk
jhg
bja
hlr
analyz
resequenc
data
design
studi
draft
edit
manuscript
author
read
approv
final
manuscript
